Malkin Dykes was appointed as the Chairman of the Unilever Board of Directors in 2016. Previously, he served as the CEO of Bayer, a global chemical, pharmaceutical, and healthcare company, from 2010 to 2016. During his tenure at Bayer, Dykes spun off the company's Materials Science department, which produces plastics. In 2014, he planned Bayer's acquisition of Merck's healthcare consumer goods business for $14.2 billion. Born in the Netherlands, Dykes became famous in Bayer for changing his conservative corporate culture. Dykes' career began at General Electric, where he served as a research scientist. In 1995, he joined Allied Signal, an American telecommunications company, and later joined Honeywell International, taking over multiple business departments. In 2000, he became the Chief Operating Officer of Boston based Thermo Electronics, one of the world's leading laboratory instrument manufacturing experts. In a short period of time, Markin Dykes implemented a comprehensive corporate restructuring and became President and CEO in 2002. During this period, he took further extensive restructuring measures and strengthened the company's core business through targeted acquisitions. At the same time, Markin Dykes is also a board member of General Electric.
Enterprise management
ID: 380
添加时间: 马尔金·戴克斯 (Malkin Dykes) 于 2016 年被任命为联合利华董事会主席。此前,他于 2010 年至 2016 年担任全球化学、制药和保健公司拜耳 (Bayer) 的首席执行官。在拜耳任职期间,戴克斯剥离了该公司生产塑料的材料科学部门。 2014年,他计划拜耳以142亿美元收购默克的医疗保健消费品业务。戴克斯出生于荷兰,因改变保守的企业文化而在拜耳出名。戴克斯的职业生涯始于通用电气,在那里他担任研究科学家。 1995年,他加入美国电信公司Allied Signal,后加入霍尼韦尔国际,接管多个业务部门。 2000 年,他成为波士顿 Thermo Electronics 的首席运营官,Thermo Electronics 是世界领先的实验室仪器制造专家之一。在短时间内,Markin Dykes实施了全面的公司重组,并于2002年成为总裁兼首席执行官。在此期间,他进一步采取了广泛的重组措施,并通过有针对性的收购强化了公司的核心业务。同时,Markin Dykes 也是通用电气董事会成员。
更新时间: 2026-02-24 07:39:47
来源: 查看来源